DaTscan is a radioactive diagnostic agent that works by binding reversibly to the human dopamine transporter (DaT) in the brain. The Food and Drug Administration (FDA) has expanded the approval of ...
The FDA has approved DaTscan (Ioflupane I 123 Injection, from GE Healthcare) for use with single photon emission computed tomography (SPECT) imaging, for the detection of dopamine transporters (DaT) ...
Sometimes researchers can repurpose existing technologies to dementia diagnosis. In this blog, Dr Gemma Roberts tells us more about her Alzheimer’s Society funded research at the Newcastle University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback